.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A16A_OtherAlimentaryTractAndMetabolismProducts.A16AX17_Triheptanoin.Triheptanoin .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A16A_OtherAlimentaryTractAndMetabolismProducts.A16AX17_Triheptanoin.Triheptanoin| name: | Triheptanoin | |
| ATC code: | A16AX17 | route: | oral |
| compartments: | 1 | |
| dosage: | 35000 | mg |
| volume of distribution: | 0.2 | L |
| clearance: | 0.7 | L/h/kg |
| other parameters in model implementation | ||
Triheptanoin is a medium-chain triglyceride comprised of three heptanoic acid chains. It is used as a source of calories and fatty acids for patients with long-chain fatty acid oxidation disorders (LC-FAOD). The drug is FDA-approved and used today for this metabolic indication.
Estimated pharmacokinetic parameters for oral administration in healthy adults, as no comprehensive published compartmental PK studies could be identified.